ITEMS IN AFP WITH KEYWORD:
Gastroesophageal Reflux Disease
May 15, 2011 Issue
Should We Screen Patients for Barrett's Esophagus? No: The Case Against Screening [Editorials: Controversies in Family Medicine]
Although there is enthusiasm in some groups for screening patients for Barrett's esophagus, with the goal of reducing death from esophageal adenocarcinoma, review of the evidence does not show sufficient benefit to recommend such a program.
Aug 1, 2010 Issue
Medical Management vs. Surgery for Gastroesophageal Reflux Disease [Cochrane for Clinicians]
At one to three years, adults with GERD who were treated with laparoscopic fundoplication had more improvement in overall and GERD-specific quality of life scores and less exposure to acid in the lower esophagus compared with patients who use proton pump inhibitors (PPIs) and histamine H2 blockers. ...
Diagnosis of GERD may be clinical (presentation with typical symptoms, such as heartburn); physiologic (evidence of abnormal pH levels in the distal esophagus); anatomic (evidence of esophagitis on endoscopy); or functional (clinical response to antacid medications). However, the correlation between these diagnostic approaches is relatively poor.
What are the effects of initial and maintenance treatment of GERD associated with esophagitis?
Gastroesophageal reflux disease typically manifests as heartburn and regurgitation, but it may also present with atypical or extraesophageal symptoms, including asthma, chronic cough, laryngitis, hoarseness, chronic sore throat, dental erosions, and noncardiac chest pain. Diagnosing atypical manifes...
Mar 1, 2008 Issue
Medical Treatments in the Short-term Management of Reflux Esophagitis [Cochrane for Clinicians]
Proton pump inhibitors (PPIs) are the most effective short-term treatment for reflux esophagitis. Histamine H2 blockers are also effective compared with placebo, but are inferior to PPIs. There is limited evidence about adverse events with these therapies, but long-term therapy with PPIs has been shown to increase hip fracture risk.
Is one PPI better than another? All PPIs are equally effective in equipotent dosages, and choice should be based on price.
Jun 15, 2005 Issue
Updated ACG Guidelines for Diagnosis and Treatment of GERD [Practice Guidelines]
The American College of Gastroenterology (ACG) has updated its guidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) to reflect the continuing advances in this area.
Thickened feeds and metoclopramide reduce symptoms of GER in normally developing infants. However, elevating the head of the crib appears to have no effect.
For empiric treatment of GERD or endoscopy-negative reflux disease, a short trial of a proton pump inhibitor increases the chance of remission. Histamine H2-receptor antagonists are less expensive and work well in many patients, particularly those with less severe symptoms or endoscopy-negative reflux disease.